Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6–producing lung carcinoma cells
Mariko Noguchi-Sasaki, Y. Sasaki, Y. Shimonaka, K. Mori, K. Fujimoto‐Ouchi
BMC Cancer